Shom Health Care

Atracurium Besylate 25mg Injection by Sunshine Healthcare under the trusted ABM Brand is a high-quality, hospital-grade neuromuscular blocking agent designed for controlled skeletal muscle relaxation during surgical procedures and intensive care management. Exclusively available at Shom Healthcare, Atracurium Besylate 25mg is widely used by anesthesiologists and critical care specialists for facilitating endotracheal intubation and providing optimal muscle relaxation during general anesthesia. Manufactured under stringent quality standards, this Atracurium Besylate 25mg injection ensures consistent potency, safety, and reliable clinical performance in operating rooms and emergency settings.
Atracurium Besylate 25mg belongs to the benzylisoquinolinium class of non-depolarizing neuromuscular blocking agents. It works by competitively binding to acetylcholine receptors at the neuromuscular junction, thereby preventing nerve impulse transmission and producing reversible skeletal muscle paralysis. Atracurium Besylate 25mg is particularly valued for its organ-independent Hofmann elimination process, making it suitable for patients with hepatic or renal impairment. This unique metabolism profile makes Atracurium Besylate 25mg Injection a preferred choice in critical care units and multi-specialty hospitals where patient safety and predictable recovery are essential.
Sunshine Healthcare’s ABM Brand Atracurium Besylate 25mg is formulated for intravenous administration and is commonly used in elective surgeries, emergency procedures, and mechanical ventilation cases. The rapid onset and intermediate duration of action of Atracurium Besylate 25mg allow precise intraoperative control, enabling anesthesiologists to adjust dosing according to surgical requirements. The product supports smooth intubation conditions and ensures adequate muscle relaxation throughout procedures, contributing to improved surgical efficiency and patient outcomes.
Atracurium Besylate 25mg Injection by Sunshine Healthcare under ABM Brand is manufactured in compliance with GMP-certified facilities, ensuring strict adherence to international pharmaceutical quality standards. Each vial of Atracurium Besylate 25mg undergoes rigorous quality checks for sterility, stability, and pharmacological efficacy. Hospitals, institutional buyers, and pharmaceutical distributors trust Shom Healthcare as the exclusive supplier of ABM Brand Atracurium Besylate 25mg due to its commitment to authenticity, proper cold chain management, and timely delivery across India and global export markets.
This Atracurium Besylate 25mg injection is packaged in secure, tamper-evident vials to maintain product integrity during storage and transportation. Recommended storage conditions are maintained to preserve the stability and effectiveness of Atracurium Besylate 25mg, ensuring optimal therapeutic performance at the time of administration. Shom Healthcare ensures that every batch of Sunshine Healthcare ABM Brand Atracurium Besylate 25mg is supplied with necessary documentation such as COA, MSDS, and other regulatory certifications upon request.
Atracurium Besylate 25mg is widely indicated in operating theaters, trauma centers, emergency departments, and intensive care units for muscle relaxation during surgery, controlled ventilation, and critical airway management. The predictable recovery profile and reduced risk of cumulative toxicity make Atracurium Besylate 25mg a dependable neuromuscular blocker for repeated dosing in prolonged surgical procedures. Healthcare professionals rely on Sunshine Healthcare’s ABM Brand Atracurium Besylate 25mg for its consistent clinical response and high safety standards.